Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $415.4800 (-0.9%) ($412.5000 - $419.5300) on Wed. Aug. 10, 2016. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.97% (three month average) | | RSI | 69 | | Latest Price | $415.4800(-0.9%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -1.2% a day on average for past five trading days. | | Weekly Trend | REGN advances 2.7% a week on average for past two weeks. | | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(62%) XLV(50%) XBI(46%) IVW(40%) IWF(40%) | | Factors Impacting REGN price | REGN will decline at least -0.985% in a week (0% probabilities).
VIXM(-9%) UUP(-7%) TLT(-7%) IPO(-6%) TIP(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.985% (StdDev 1.97%) | | Hourly BBV | 0 () | | Intraday Trend | -0.8% | | | | | |
|
| 5 Day Moving Average | $422.43(-1.65%) | | 10 Day Moving Average | $425.74(-2.41%) | | 20 Day Moving Average | $407.75(1.9%) | | To recent high | -5.9% | | To recent low | 25.5% | | Market Cap | $44.053b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |